Brief: VBL Therapeutics Announces Enrollment Of The First Patients In The Phase 2 Clinical Trial Of Vb-111 In Metastatic Colorectal Cancer
10/09/2020 14:49
Sept 10 (Reuters) - Vascular Biogenics Ltd VBLT.O :
* VBL THERAPEUTICS ANNOUNCES ENROLLMENT OF THE FIRST
PATIENTS IN
THE PHASE 2 CLINICAL TRIAL OF VB-111 IN METASTATIC COLORECTAL
CANCER
Source text for Eikon: ID:nGNX2HZJ4v
Further company coverage: VBLT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Notable Labs
See all newsUS STOCKS-Wall St ends sharply lower following Trump's anti-Powell tirade
US STOCKS-Wall St ends sharply lower amid Trump's tirade against Fed's Powell
US STOCKS-Wall St tumbles as Trump ramps up tirade against Fed's Powell
Brief: Notable Labs Says Co, Units Filed Voluntary Petition Under Provisions Of Chapter 7 Of Title 11 Of US Bankruptcy Code
Brief: Notable Labs Approved A Streamlined Operating Plan Which Includes Exploring Strategic Alternatives